China Gives Conditional Clearance To $4 Billion Baxter-Gambro Merger
This article was originally published in PharmAsia News
Executive Summary
China offered conditional approval of Baxter International's $4 billion acquisition of Gambro along the lines of a previous clearance by the European Union.